An In Vivo Method to Quantify Lymphangiogenesis in Zebrafish

PLoS ONE

Volumn 7, Issue 9, 2012, Pages

  Hoffman, Scott J ^a   Psaltis, Peter J ^a   Clark, Karl J ^a   Spoon, Daniel B ^a   Chue, Colin D ^a   Ekker, Stephen C ^a   Simari, Robert D ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; VASCULOTROPIN C;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; EMBRYO; ENDOTHELIUM CELL; IN VIVO STUDY; LARVA; LYMPHANGIOGENESIS; MELANOMA CELL; MICROANGIOGRAPHY; NONHUMAN; XENOTRANSPLANTATION; ZEBRA FISH;

ANIMALS; EMBRYO, NONMAMMALIAN; ENDOTHELIAL CELLS; FLUORESCEIN ANGIOGRAPHY; FLUORESCENT DYES; HUMANS; LYMPHANGIOGENESIS; LYMPHATIC VESSELS; MELANOMA; MODELS, BIOLOGICAL; MORPHOLINOS; TUMOR CELLS, CULTURED; VASCULAR ENDOTHELIAL GROWTH FACTOR C; ZEBRAFISH;

DANIO RERIO;

EID: 84866374304     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0045240     Document Type: Article

References (34)

1. Alitalo K, Tammela T, Petrova TV, (2005) Lymphangiogenesis in development and human disease. Nature 438: 946-953.
2. Jones D, Min W, (2011) An overview of lymphatic vessels and their emerging role in cardiovascular disease. J Cardiovasc Dis Res 2: 141-152.
3. Kholova I, Dragneva G, Cermakova P, Laidinen S, Kaskenpaa N, et al. (2011) Lymphatic vasculature is increased in heart valves, ischaemic and inflamed hearts and in cholesterol-rich and calcified atherosclerotic lesions. Eur J Clin Invest 41: 487-497.
4. Wada H, Ura S, Kitaoka S, Satoh-Asahara N, Horie T, et al. (2011) Distinct characteristics of circulating vascular endothelial growth factor-A and C levels in human subjects. PLoS One 6: e29351.
5. Bruyere F, Noel A, (2010) Lymphangiogenesis: in vitro and in vivo models. FASEB J. 224: 8-21.
6. Cao R, Lim S, Ji H, Zhang Y, Yang Y, et al. (2011) Mouse corneal lymphangiogenesis model. Nat Protoc 6: 817-826.
7. Bhang SH, Won N, Lee TJ, Jin H, Nam J, et al. (2009) Hyaluronic acid-quantum dot conjugates for in vivo lymphatic vessel imaging. ACS Nano 23: 1389-1398.
8. Pan D, Suzuki Y, Yang PC, Rockson SG, (2006) Indirect magnetic resonance lymphangiography to assess lymphatic function in experimental murine lymphedema. Lymphat Res Biol 4: 211-216.
9. Raghunath M, Wong YS, Farooq M, Ge R, (2009) Pharmacologically induced angiogenesis in transgenic zebrafish. Biochem Biophys Res Commun 378: 766-771.
10. Flores MV, Hall CJ, Crosier KE, Crosier PS, (2010) Visualization of embryonic lymphangiogenesis advances the use of the zebrafish model for research in cancer and lymphatic pathologies. Dev Dynam 239: 2128-2135.
11. Yaniv K, Isogai S, Castranova D, Dye L, Hitomi J, Weinstein BM, (2006) Live imaging of lymphatic development in zebrafish. Nat Med 12: 711-716.
12. Banziger-Tobler NE, Halin C, Kajiya K, Detmar M, (2008) Growth hormone promotes lymphangiogenesis. Am J Pathol 173: 586-597.
13. Lawson ND, Weinstein BM, (2002) In vivo imaging of embryonic vascular development using transgenic zebrafish. Dev Biol 248: 307-318.
14. Nwariaku FE, Liu Z, Zhu X, Nahari D, Ingle C, et al. (2004) NADPH oxidase mediates vascular endothelial cadherin phosphorylation and endothelial dysfunction. Blood 104: 3214-3220.
15. Lund AW, Duraes FV, Hirosue S, Raghavan VR, Nembrini C, (2012) VEGF-C promotes immune tolerance in B16 melanomas and cross-presentation of tumor antigen by lymph node lymphatics. Cell Rep 1: 191-199.
16. Weich HA, Bando H, Brokelmann M, Baumann P, Toi M, et al. (2004) Quantification of vascular endothelial growth factor-C (VEGF-C) by a novel ELISA. J Immunol Methods 285: 145-155.
17. Nasevicius A, Ekker S, (2000) Effective targeted gene 'knockdown' in zebrafish. Nat Genet 26: 216-220.
18. Traver D, Paw BH, Poss KD, Penberthy WT, Lin A, et al. (2003) Transplantation and in vivo imaging of multilineage engraftment in zebrafish bloodless mutants. Nat Immunol 4: 1238-1246.
19. Weinstein BM, Stemple DL, Driever W, Fishman MC, (1995) gridlock, a localized heritable vascular patterning defect in the zebrafish. Nat Med 1: 1143-1147.
20. Pozzoli O, Vella P, Iaffaldano G, Parente V, Devanna P, et al. (2011) Endothelial fate and angiogenic properties of human CD34+ progenitor cells in zebrafish. Arterioscler Thromb Vasc Biol 31: 1589-1597.
21. Stoletov K, Fang L, Choi SH, Hartvigsen K, Hansen LF, et al. (2009) Vascular lipid accumulation, lipoprotein oxidation, and macrophage lipid uptake in hypercholesterolemic zebrafish. Circ Res 104: 952-960.
22. Henry CA, McNulty IM, Durst WA, Munchel SE, Amacher SL, (2005) Interactions between muscle fibers and segment boundaries in zebrafish. Dev Biol 287: 346-360.
23. Cooke JP, (2012) Lymphangiogenesis: a potential new therapy for lymphedema? Circulation 125: 853-855.
24. Kirkin V, Thiele W, Baumann P, Mazitschek R, Rohde K, et al. (2004) MAZ51, an indolinone that inhibits endothelial cell and tumor growth in vitro, suppresses tumor growth in vivo. Int J Cancer 112: 986-993.
25. Ny A, Koch M, Vandevelde W, Schneider M, Fischer C, et al. (2008) Role of Vegf-D and VegfR-3 in developmental lymphangiogenesis, a chemicogenetic study in Xenopus tadpoles. Blood 112: 1740-1749.
26. Makky K, Tekiela J, Mayer AN, (2007) Target of rapamycin (TOR) signaling controls epithelial morphogenesis in the vertebrate intestine. Dev Biol 303: 501-513.
27. Huber S, Bruns CJ, Schmid G, Hermann PC, Conrad C, et al. (2007) Inhibition of the mammalian target of rapamycin impedes lymphangiogenesis. Kidney Int 71: 771-777.
28. Luo Y, Liu L, Rogers D, Su W, Odaka Y, et al. (2012) Rapamycin inhibits lymphatic endothelial cell tube formation by downregulating vascular endothelial growth factor receptor 3 protein expression. Neoplasia 14: 228-237.
29. Patel V, Marsh CA, Dorsam RT, Mikelis CM, Masedunksas A, et al. (2011) Decreased lymphangiogenesis and lymph node metastasis by mTOR inhibition in head and neck cancer. Cancer Res 71: 7103-7112.
30. Kobayashi S, Kishimoto T, Kamata S, Otsuka M, Miyazaki M, et al. (2007) Rapamycin, a specific inhibitor of the mammalian target or rapamycin, suppresses lymphangiogenesis and lymphatic metastasis. Cancer Sci 98: 726-733.
31. Lohela M, Bry M, Tammela T, Alitalo K, (2009) VEGFs and receptors involved in angiogenesis versus lymphangiogenesis. Curr Opin Cell Biol 21: 154-165.
32. Cursiefen C, Maruyama K, Jackson DG, Streilein W, Kruse FE, (2006) Time course of angiogenesis and lymphangiogenesis after brief corneal inflammation. Cornea 25: 443-447.
33. Nakao S, Zandi S, Hata Y, Kawahara S, Arita R, et al. (2011) Blood vessel endothelial VEGFR-2 delays lymphangiogenesis: an endogenous trapping mechanism links lymph- and angiogenesis. Blood 117: 1081-1090.
34. Padera TP, Kadambi A, Di Tomaso E, Carreira CM, Brown EB, et al. (2002) Lymphatic metastasis in the absence of functional intratumor lymphatics. Science 296: 1883-1886.